266 related articles for article (PubMed ID: 28923878)
1.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923878
[TBL] [Abstract][Full Text] [Related]
2.
Brown-Elliott BA; Wallace RJ
J Clin Microbiol; 2017 Jun; 55(6):1747-1754. PubMed ID: 28330892
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.
Biedenbach DJ; Bouchillon SK; Johnson B; Alder J; Sahm DF
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1933-1939. PubMed ID: 27677280
[TBL] [Abstract][Full Text] [Related]
4. Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
Pfaller MA; Flamm RK; Jones RN; Farrell DJ; Mendes RE
Antimicrob Agents Chemother; 2016 Sep; 60(9):5393-9. PubMed ID: 27353270
[TBL] [Abstract][Full Text] [Related]
5. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
Karlowsky JA; Hackel MA; Bouchillon SK; Alder J; Sahm DF
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):151-157. PubMed ID: 28793964
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections.
Littorin C; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1549-1552. PubMed ID: 28326447
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of Tedizolid phosphate against multidrug-resistant Streptococcus pneumoniae isolates from Asian countries.
Baek JY; Kang CI; Kim SH; Ko KS; Chung DR; Peck KR; Hsueh PR; Thamlikitkul V; So TM; Lee NY; Song JH;
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):218-20. PubMed ID: 27083121
[TBL] [Abstract][Full Text] [Related]
9. Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.
Sahm DF; Deane J; Bien PA; Locke JB; Zuill DE; Shaw KJ; Bartizal KF
Diagn Microbiol Infect Dis; 2015 Feb; 81(2):112-8. PubMed ID: 25488274
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid.
Vanegas Múnera JM; Ocampo Ríos AM; Urrego DM; Jiménez Quiceno JN
Braz J Infect Dis; 2017; 21(5):493-499. PubMed ID: 28432878
[TBL] [Abstract][Full Text] [Related]
12. Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone.
Zurenko G; Bien P; Bensaci M; Patel HN; Thorne G
Ann Clin Microbiol Antimicrob; 2014 Sep; 13():46. PubMed ID: 25238753
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of in vitro activity of tedizolid and linezolid against Mycobacterium avium complex.
Marfil E; Ruiz P; Martínez-Martínez L; Causse M
J Glob Antimicrob Resist; 2022 Sep; 30():395-398. PubMed ID: 35863729
[TBL] [Abstract][Full Text] [Related]
14. Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.
Klupp EM; Both A; Belmar Campos C; Büttner H; König C; Christopeit M; Christner M; Aepfelbacher M; Rohde H
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1957-1961. PubMed ID: 27525679
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility profiles of Nocardia isolates based on current taxonomy.
Schlaberg R; Fisher MA; Hanson KE
Antimicrob Agents Chemother; 2014; 58(2):795-800. PubMed ID: 24247124
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
Prokocimer P; Bien P; Deanda C; Pillar CM; Bartizal K
Antimicrob Agents Chemother; 2012 Sep; 56(9):4608-13. PubMed ID: 22687509
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.
Vera-Cabrera L; Gonzalez E; Rendon A; Ocampo-Candiani J; Welsh O; Velazquez-Moreno VM; Choi SH; Molina-Torres C
Antimicrob Agents Chemother; 2006 Sep; 50(9):3170-2. PubMed ID: 16940121
[TBL] [Abstract][Full Text] [Related]
18. Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.
Conville PS; Brown-Elliott BA; Wallace RJ; Witebsky FG; Koziol D; Hall GS; Killian SB; Knapp CC; Warshauer D; Van T; Wengenack NL; Deml S; Woods GL
J Clin Microbiol; 2012 Apr; 50(4):1270-80. PubMed ID: 22219309
[TBL] [Abstract][Full Text] [Related]
19. Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China.
Wei M; Wang P; Qu J; Li R; Liu Y; Gu L; Yang C
J Glob Antimicrob Resist; 2017 Dec; 11():183-187. PubMed ID: 28870771
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.
Lai CC; Liu WL; Ko WC; Chen YH; Tan HR; Huang YT; Hsueh PR
Antimicrob Agents Chemother; 2011 May; 55(5):2084-91. PubMed ID: 21343461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
